Invention Grant
- Patent Title: Farnesoid X receptor agonists and uses thereof
-
Application No.: US16872985Application Date: 2020-05-12
-
Publication No.: US11214538B2Publication Date: 2022-01-04
- Inventor: Nicholas D. Smith , Steven P. Govek , Johnny Y. Nagasawa
- Applicant: Metacrine, Inc.
- Applicant Address: US CA San Diego
- Assignee: Metacrine, Inc.
- Current Assignee: Metacrine, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07C233/80
- IPC: C07C233/80 ; C07C233/63 ; A61K31/167 ; A61K31/216 ; C07D333/32 ; C07D239/34 ; C07D241/18 ; C07D263/32 ; C07D205/04 ; C07D207/27 ; C07D275/03 ; C07D277/34 ; C07D213/65 ; A61K45/06 ; C07D207/12 ; C07D213/75 ; C07D207/08 ; C07D213/68 ; C07D211/42 ; C07D211/46 ; C07D213/40 ; C07D213/64 ; C07D213/80 ; C07C271/20 ; C07C237/22 ; C07C237/42 ; C07C233/59 ; C07C233/62 ; A61K31/381 ; A61K31/397 ; A61K31/40 ; A61K31/4015 ; A61K31/421 ; A61K31/425 ; A61K31/426 ; A61K31/4418 ; A61K31/445 ; A61K31/4965 ; A61K31/505 ; C07D207/24 ; C07D211/94
Abstract:
Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
Public/Granted literature
- US20210032195A1 FARNESOID X RECEPTOR AGONISTS AND USES THEREOF Public/Granted day:2021-02-04
Information query
